InvestorsHub Logo
Followers 17
Posts 1580
Boards Moderated 0
Alias Born 02/07/2007

Re: MLD38 post# 20

Thursday, 05/31/2007 12:07:05 AM

Thursday, May 31, 2007 12:07:05 AM

Post# of 488
ISIS's CEO, Stanley Crooke stated during their annual presentation that IBIS is transitioning from a research to a revenue generating division with the intention of spinning it off. They anticipate revenues to ramp-up quickly and estimate up to $150 million by 2010 just from the sale of the assay kits.

This division could support the entire clinical development program and I can't imagine how much they can sell it for. They can't hold the share price down for much longer.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IONS News